David Wilson breaks down the wins, stumbles and global ambitions of ASX giants such as WiseTech, CSL and Woolworths – and pitches why Australia is still a top bet. Fireside chats were in and ...

It’s a day before Easter — and 4/20. There was a time when it’d be a sure bet to think Spacey Kacey would be out there in nature, lighting up in early celebration. But on the title track to ...

SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--Travere Therapeutics, Inc., (NASDAQ: TVTX) and CSL Vifor are pleased to announce that the European Commission has approved the conversion of ...

SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--$TVTX--Travere Therapeutics, Inc., (NASDAQ: TVTX) and CSL Vifor are pleased to announce that the European ...

Tim Johnston has only worked for Tyndall Asset Management, at least while he has been in the business of stock picking. After joining the Australian equities fund manager 26 years ago as a trainee ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Udupi Cochin Shipyard Ltd (Udupi-CSL), a wholly owned subsidiary of Cochin Shipyard Ltd has delivered the first in series of six 3800 T DW dry cargo vessels to Wilson Ship Management AS ...

Labor’s plan for an unrealised capital gains tax on super­annuation accounts has been ­denounced by CSL chairman Brian McNamee and veteran UBS dealmaker Brett Paton, who say it will cost jobs ...

Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...

Building envelope solutions provider Carlisle Companies (NYSE:CSL) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. Carlisle missed analysts’ revenue ...

TOKYO- 18 April 2025 – CSL Behring K.K. (Headquarters: Minato-ku, Tokyo; President and Representative Director: Izumi Yoshida) today announced that it launched ANDEMBRY® Subcutaneous Injection 200 mg ...